This was a really interesting article, because it gives a glimpse of the economic reality of the American medical system. Among the parties involved - doctors, pharmaceutical companies, lawyers, and patients, there is but one incentive: do more, prescribe more, treat more. Whether patients are helped or hurt by these treatments seems to be of minimal concern, and certainly nobody is doing a cost-benefit analysis. It is as if financial resources were infinite.
http://www.bloomberg.com/news/2012-12-20/how-many-billions-a-year-will-the-dsm-5-cost-.html
Read the comments at the bottom, too.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment